CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
7.3075
1.61%
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.0300
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023255 %
Charges from full value of position ($-4.42)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023255%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001338 %
Charges from full value of position ($0.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001338%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency GBP
Margin 5.00%
Stock exchange United Kingdom of Great Britain and Northern Ireland
Commission on trade 0%

Key Stats
Prev. Close 7.427
Open 7.502
1-Year Change -55.72%
Day's Range 7.2525 - 7.557
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2025 7.3075 -0.1795 -2.40% 7.4870 7.5870 7.1875
Mar 27, 2025 7.4270 0.0545 0.74% 7.3725 7.6620 7.1475
Mar 26, 2025 7.4525 0.1050 1.43% 7.3475 7.5370 7.2025
Mar 25, 2025 7.3725 -0.3595 -4.65% 7.7320 7.8620 7.3725
Mar 24, 2025 7.7070 0.2100 2.80% 7.4970 7.7320 7.4820
Mar 21, 2025 7.3125 -0.0250 -0.34% 7.3375 7.5120 7.1475
Mar 20, 2025 7.3675 -0.2695 -3.53% 7.6370 7.6870 7.3675
Mar 19, 2025 7.6370 0.2095 2.82% 7.4275 7.6920 7.3675
Mar 18, 2025 7.3125 -0.1795 -2.40% 7.4920 7.7470 7.3125
Mar 17, 2025 7.4870 0.1195 1.62% 7.3675 7.5570 7.2925
Mar 14, 2025 7.4375 0.1050 1.43% 7.3325 7.6270 7.2325
Mar 13, 2025 7.3975 0.0550 0.75% 7.3425 7.5370 7.3375
Mar 12, 2025 7.3425 -0.1145 -1.54% 7.4570 7.7920 7.3075
Mar 11, 2025 7.4025 0.2150 2.99% 7.1875 7.4325 6.8580
Mar 10, 2025 7.0825 -0.1900 -2.61% 7.2725 7.4225 6.8580
Mar 7, 2025 7.3025 -0.2045 -2.72% 7.5070 7.6670 7.1975
Mar 6, 2025 7.5870 -0.0800 -1.04% 7.6670 7.7670 7.2725
Mar 5, 2025 7.4320 -0.3950 -5.05% 7.8270 8.0565 7.3075
Mar 4, 2025 7.2125 -0.2245 -3.02% 7.4370 7.6070 7.0775
Mar 3, 2025 7.4620 0.3295 4.62% 7.1325 7.7120 7.0625

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Indivior Company profile

About Indivior PLC

Indivior PLC is a United Kingdom-based pharmaceutical company. The Company is engaged in developing medicines to treat addiction and serious mental illnesses. It focuses to build a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and cooccurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as new therapies to address the needs of people suffering from alcohol, stimulant and cannabis use disorders. Its pipeline products include INDV-3000 - Selective Dopamine D3-receptor Antagonist, RBP-6000 - Buprenorphine XR injection, Buprenorphine/ Naloxone Sublingual Film, Buprenorphine/ Naloxone Sublingual Tablet and Buprenorphine Sublingual Tablet, among others. Its portfolio of products is available in more than 40 countries.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Indivior PLC revenues increased 22% to $791M. Net income totaled $205M vs. loss of $148M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Other operating income increase from $0K to $32M (income), Selling/General/Admin. Expense, decrease of 5% to $192M (expense).

Industry: Proprietary & Advanced Pharmaceuticals

234 Bath Road
SLOUGH
BERKSHIRE SL1 4EE
GB

People also watch

US100

19,177.30 Price
-3.190% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

82,173.40 Price
-2.030% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

Gold

3,085.52 Price
+0.940% 1D Chg, %
Long position overnight fee -0.0171%
Short position overnight fee 0.0089%
Overnight fee time 21:00 (UTC)
Spread 0.30

ETH/USD

1,838.84 Price
-2.170% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

Still looking for a broker you can trust?

Join the 710,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading